Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36
Open Access
- 19 January 2017
- journal article
- research article
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 13 (1), 1-5
- https://doi.org/10.1186/s13223-016-0176-3
Abstract
Hereditary angioedema (HAE) is a rare but serious condition characterized by recurrent spontaneous attacks of angioedema affecting superficial tissues of upper respiratory and gastrointestinal tracts. The potentially fatal and disfiguring nature of HAE impacts the health-related quality of life (HRQoL) of patients with this condition. To assess the health-related quality of life of Canadian patients with HAE using the 36-item Short-Form Health Survey (SF-36v2). Twenty-one patients living in Canada over age 18 with known diagnosis of hereditary angioedema due to C1-INH deficiency (HAE), completed the SF-36v2 (generic HRQoL questionnaire). Results were compared to Canadian normative data by converting the SF-36 scores into z scores. The SF-36v2 showed a significant reduction in general health (p = 0.0063) in patients with HAE when compared with healthy Canadians. Percentage of patients with z scores below 0.8 (large effect) was 47.6% for general health subscale, 33.3% for bodily pain and vitality subscales and 28.6% for physical component scores. Mean scores of eight dimensions ranged from 57.7 to 88.9. Mean Physical and mental component scores were 49.1 and 50.4. Internal consistency of evaluation was demonstrated by Cronbach’s alpha value above 0.7 for all scales. General perception of health was significantly different in these patients, compared to Canadian normative data. This study of Canadian patients with HAE shows that General Health is most frequently affected followed by Bodily Pain and Vitality, as measured by SF-36v2. The SF-36v2 offers valuable insight to assess quality of life in patients with HAE, however a larger number of Canadian patients and specific tools for assessment are needed for better evaluation.Keywords
Funding Information
- CSL Behring
This publication has 11 references indexed in Scilit:
- Upper airway edema in 43 patients with hereditary angioedemaAnnals of Allergy, Asthma & Immunology, 2014
- Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiencyBMC Gastroenterology, 2014
- A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedemaJournal of Allergy and Clinical Immunology, 2013
- The Aberdeen Varicose Vein Questionnaire May be the Preferred Method of Rationing Patients for Varicose Vein SurgeryAngiology, 2013
- Hereditary angioedema: quality of life in Brazilian patientsClinics, 2013
- Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research projectHealth and Quality of Life Outcomes, 2012
- The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depressionAllergy and Asthma Proceedings, 2010
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy, Asthma & Clinical Immunology, 2010
- Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefitsEuropean Journal Of Dermatology, 2009
- Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.2000